Efficacy of an Abbreviated Induction Regimen of Amphotericin B Deoxycholate for Cryptococcal Meningoencephalitis: 3 Days of Therapy Is Equivalent to 14 Days
Cryptococcal meningoencephalitis is an urgent global health problem. Induction regimens using 14 days of amphotericin B deoxycholate (dAmB) are considered the standard of care but may not be suitable for resource-poor settings. We investigated the efficacy of conventional and abbreviated regimens of...
Main Authors: | Livermore, Joanne, Howard, Susan J., Sharp, Andrew D., Goodwin, Joanne, Gregson, Lea, Felton, Timothy, Schwartz, Julie A., Walker, Catherine, Moser, Bill, Müller, Werner, Harrison, Thomas S., Perfect, John R., Hope, William W. |
---|---|
Format: | Online |
Language: | English |
Published: |
American Society of Microbiology
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903272/ |
Similar Items
-
Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa
by: Meiring, Susan, et al.
Published: (2016) -
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
by: Bicanic, Tihana, et al.
Published: (2015) -
Concurrent presentation of cryptococcal meningoencephalitis and systemic lupus erythematosus
by: Matsumura, Masami, et al.
Published: (2010) -
A case report of cryptococcal meningoencephalitis presenting as uveitis
by: Abhyankar, Nikita, et al.
Published: (2012) -
A Case of Recurrent Cryptococcal Meningoencephalitis in an Immunocompetent Female
by: Niknam, Negin, et al.
Published: (2014)